Your browser doesn't support javascript.
loading
ADRB2 signaling promotes HCC progression and sorafenib resistance by inhibiting autophagic degradation of HIF1α.
Wu, Fu-Quan; Fang, Tian; Yu, Le-Xing; Lv, Gui-Shuai; Lv, Hong-Wei; Liang, Dong; Li, Ting; Wang, Chang-Zheng; Tan, Ye-Xiong; Ding, Jin; Chen, Yao; Tang, Liang; Guo, Lin-Na; Tang, Shan-Hua; Yang, Wen; Wang, Hong-Yang.
Afiliação
  • Wu FQ; International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Institute, Second Military Medical University, Shanghai 200438, PR China.
  • Fang T; International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Institute, Second Military Medical University, Shanghai 200438, PR China.
  • Yu LX; International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Institute, Second Military Medical University, Shanghai 200438, PR China; National Center for Liver Cancer Research, Shanghai, PR China.
  • Lv GS; International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Institute, Second Military Medical University, Shanghai 200438, PR China; National Center for Liver Cancer Research, Shanghai, PR China.
  • Lv HW; International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Institute, Second Military Medical University, Shanghai 200438, PR China.
  • Liang D; International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Institute, Second Military Medical University, Shanghai 200438, PR China.
  • Li T; International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Institute, Second Military Medical University, Shanghai 200438, PR China.
  • Wang CZ; International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Institute, Second Military Medical University, Shanghai 200438, PR China.
  • Tan YX; International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Institute, Second Military Medical University, Shanghai 200438, PR China; National Center for Liver Cancer Research, Shanghai, PR China.
  • Ding J; International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Institute, Second Military Medical University, Shanghai 200438, PR China; National Center for Liver Cancer Research, Shanghai, PR China.
  • Chen Y; International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Institute, Second Military Medical University, Shanghai 200438, PR China; National Center for Liver Cancer Research, Shanghai, PR China.
  • Tang L; International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Institute, Second Military Medical University, Shanghai 200438, PR China; National Center for Liver Cancer Research, Shanghai, PR China.
  • Guo LN; International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Institute, Second Military Medical University, Shanghai 200438, PR China; National Center for Liver Cancer Research, Shanghai, PR China.
  • Tang SH; International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Institute, Second Military Medical University, Shanghai 200438, PR China; National Center for Liver Cancer Research, Shanghai, PR China.
  • Yang W; International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Institute, Second Military Medical University, Shanghai 200438, PR China; National Center for Liver Cancer Research, Shanghai, PR China. Electronic address: woodeasy66@hotmail.com.
  • Wang HY; International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Institute, Second Military Medical University, Shanghai 200438, PR China; National Center for Liver Cancer Research, Shanghai, PR China; State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Ins
J Hepatol ; 65(2): 314-24, 2016 08.
Article em En | MEDLINE | ID: mdl-27154061

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article